Further, ABCB5+ melanoma CSCs preferentially inhibited IL-2–dependent T-cell activation in a CD86-dependent manner and induced CD4+CD25+FoxP3+ regulatory T cells (T-regs) [33]. Here, CD86 is linked to melanoma.